Compare CDMOs with EMA GMP certification for EU-market pharmaceutical manufacturing. Filter by product type, member state, and manufacturing capabilities.
349 companies listed
EMA (European Medicines Agency) GMP certification confirms that a manufacturing facility complies with EU Good Manufacturing Practice standards. GMP inspections are conducted by national competent authorities (e.g., BfArM in Germany, ANSM in France, MHRA in the UK) and the resulting GMP certificates are recognized across the EU through mutual recognition.
The EMA maintains Mutual Recognition Agreements with regulatory agencies in the US, Canada, Australia, Japan, Switzerland, and other countries. This means EU GMP inspections may be accepted by these agencies without re-inspection, reducing the regulatory burden on CDMOs serving multiple markets. The Qualified Person (QP) system -- unique to the EU -- provides an additional layer of batch release oversight.
Germany
Vetter Pharma is a leading global Contract Development and Manufacturing Organization specializing in aseptic fill-and-finish services for injectable drug products. Headquartered in Ravensburg, Germany, Vetter operates as an independent, family-owned business with over 75 years of experience.
Spain
Curapath is a European CDMO specialized in polymer- and lipid-based non-viral drug delivery systems, supporting programs from preclinical through commercial manufacturing. The company has expertise in lipid nanoparticle (LNP) formulations, polymer excipients, and nanoparticle formulations for cell and gene therapy applications. Curapath operates manufacturing facilities in Valencia, Spain and has offices in Cambridge, Massachusetts.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.